+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genetic Disease Diagnostics Market Size, Share & Trends Analysis Report by Technology (NGS, PCR-based Testing), Channel (Online, Offline), Application, Product, End Use and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 6214536
REQUEST CUSTOMIZATION
Description Jump to:
The global genetic disease diagnostics market size was estimated at USD 11.71 billion in 2024 and is projected to reach USD 57.83 billion by 2033, growing at a CAGR of 19.1% from 2025 to 2033. The market is primarily driven by technological advancements, increasing demand for personalized medicine, and growing demand for newborn screening..

Genetic testing in maternity care is undergoing a major transformation, driven by advancements in carrier screening, non-invasive prenatal testing (NIPT), and IVF-related genetic analyses. These innovations are fueling consistent market growth, especially across both established and emerging economies.

Pharmacogenomics testing is increasingly vital in helping clinicians choose the most effective medications and appropriate dosages for patients. The Association for Molecular Pathology (AMP) has made strides toward standardizing these tests across laboratories. In August 2022, the AMP released recommendations for designing and validating clinical genotyping assays for genes like NUDT15 and TPMT. These guidelines provide a minimum set of alleles for laboratories to identify patients who may be at a higher risk of thiopurine toxicity, thereby improving treatment safety and efficacy.

The introduction of new tests that can considerably reduce treatment costs and help lower pharmaceutical expenses by preventing overprescription and excessive dosing, while also reducing the risk of complications and hospitalizations resulting from adverse drug reactions, is expected to impact market growth positively. For instance, in October 2025, AIG Hospitals, a Hyderabad (India) based hospital, in collaboration with GenepowerRx, launched a pharmacogenomics test that would help doctors to prescribe medicines or decide on a treatment plan based on the patient's genetic makeup.

Driven primarily by advancements in Next-Generation Sequencing (NGS) technology, WGS costs are falling toward the sub-USD 100 threshold. Many companies have launched new tests based on next-generation sequencing (NGS), whole-genome sequencing, and advanced array technologies, offering higher accuracy, coverage, and rapid results. For instance, CENTOGENE launched CentoGenome Ultra-Fast, a whole-genome sequencing tool for diagnosing genetic diseases in five business days. Rapid diagnosis and early intervention facilitate timely treatment, which in turn improves patient outcomes and reduces complications in emergency cases and the ICU.

Despite these advancements, the high cost of the test may impede market growth in developing countries. Depending on the test's complexity, costs can range from under $100 to over $2,000, with higher costs associated with tests that require multiple family samples. Results may also take weeks to arrive. In some instances, health insurance covers these tests when prescribed by a medical professional, but coverage varies widely across insurers and policies.

Global Genetic Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global genetic disease diagnostics market report based on technology, application, product, channel, end use, and region:

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Next Generation Sequencing
  • Array Technology
  • PCR-based Testing
  • FISH
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Ancestry & Ethnicity
  • Traits Screening
  • Genetic Disease Carrier Status
  • New Baby Screening
  • Health and Wellness-Predisposition/Risk/Tendency

Product Outlook (Revenue, USD Million, 2021-2033)

  • Consumables
  • Equipment
  • Software & Services

Channel Outlook (Revenue, USD Million, 2021-2033)

  • Online
  • Offline

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. Product
1.2.4. Channel
1.2.5. End Use
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia-Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. Product outlook
2.2.4. Channel outlook
2.2.5. End Use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Genetic Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological Advancements in Diagnostic Testing
3.2.1.2. Growing Burden of Chronic and Infection Diseases
3.2.1.3. Rising Awareness and Demand for Personalized Medicine
3.2.2. Market restraint analysis
3.2.2.1. Required Skilled Labors
3.3. Genetic Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Genetic Disease Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Genetic Disease Diagnostics Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
4.4.1. Next-Generation Sequencing
4.4.1.1. Market estimates and forecasts, 2021-2033 (USD million)
4.4.2. Array Technology
4.4.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.4.3. PCR - Based Testing
4.4.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.4.4. FISH
4.4.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.4.5. Others
4.4.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Genetic Disease Diagnostics Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Genetic Disease Diagnostics Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
5.4.1. Ancestry & Ethnicity
5.4.1.1. Market estimates and forecasts, 2021-2033 (USD million)
5.4.2. Traits Screening
5.4.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.4.3. Genetic Disease Carrier Status
5.4.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.4.4. New Baby Screening
5.4.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.4.5. Health and Wellness - Predisposition/ Risk/tendency
5.4.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. Genetic Disease Diagnostics Market: Product Estimates & Trend Analysis
6.1. Product Market Share, 2024 & 2033
6.2. Segment Dashboard
6.3. Global Genetic Disease Diagnostics Market by Product Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
6.4.1. Consumables
6.4.1.1. Market estimates and forecasts, 2021-2033 (USD million)
6.4.2. Equipment
6.4.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.4.3. Software & Services
6.4.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Genetic Disease Diagnostics Market: Channel Estimates & Trend Analysis
7.1. Channel Market Share, 2024 & 2033
7.2. Segment Dashboard
7.3. Global Genetic Disease Diagnostics Market by Channel Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
7.4.1. Online
7.4.1.1. Market estimates and forecasts, 2021-2033 (USD million)
7.4.2. Offline
7.4.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. Genetic Disease Diagnostics Market: End Use Estimates & Trend Analysis
8.1. End Use Market Share, 2024 & 2033
8.2. Segment Dashboard
8.3. Global Genetic Disease Diagnostics Market by End Use Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
8.4.1. Hospitals & Clinics
8.4.1.1. Market estimates and forecasts, 2021-2033 (USD million)
8.4.2. Diagnostic Laboratories
8.4.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
8.4.3. Others
8.4.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 9. Genetic Disease Diagnostics Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2024 & 2033
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts, 2021-2033 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts, 2021-2033 (USD Million)
9.5.3. Mexico
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. Mexico market estimates and forecasts, 2021-2033 (USD Million
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts, 2021-2033 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts, 2021-2033 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts, 2021-2033 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/ reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts, 2021-2033 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/ reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts, 2021-2033 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/ reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts, 2021-2033 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/ reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts, 2021-2033 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/ reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts, 2021-2033 (USD Million)
9.7. Asia-Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts, 2021-2033 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts, 2021-2033 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts, 2021-2033 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts, 2021-2033 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/ reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts, 2021-2033 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/ reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts, 2021-2033 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/ reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts, 2021-2033 (USD Million)
9.8.2. Argentina
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/ reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Argentina market estimates and forecasts, 2021-2033 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/ reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts, 2021-2033 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/ reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/ reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts, 2021-2033 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/ reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2024
10.3.4. 24 genetics
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Circle DNA
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. TellmeGen
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. 23andme
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. AncestryDNA
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. MyDNA
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Igenomix
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Myriad Genetics, Inc
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Illumina, Inc.
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. MyHeritage Ltd.
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Everly Well.
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. VitaGen
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Mapmygenome
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Helix OpCo LLC
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Color Genomics, Inc.
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
10.3.19. Amgen, Inc.
10.3.19.1. Company overview
10.3.19.2. Financial performance
10.3.19.3. Product benchmarking
10.3.19.4. Strategic initiatives
10.3.20. Beyond Nutrition Health and Wellness Services DMCC.
10.3.20.1. Company overview
10.3.20.2. Financial performance
10.3.20.3. Product benchmarking
10.3.20.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 4 Global Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 5 Global Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 6 Global Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 7 Global Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 8 Global Genetic Disease Diagnostics Market, by Region, 2021-2033 (USD Million)
Table 9 North America Genetic Disease Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 10 North America Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 11 North America Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 12 North America Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 13 North America Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 14 North America Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 15 U.S. Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 16 U.S. Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 17 U.S. Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 18 U.S. Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 19 U.S. Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 20 Canada Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 21 Canada Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 22 Canada Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 23 Canada Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 24 Canada Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 25 Europe Genetic Disease Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 26 Europe Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 27 Europe Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 28 Europe Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 29 Europe Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 30 Europe Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 31 Germany Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 32 Germany Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 33 Germany Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 34 Germany Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 35 Germany Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 36 UK Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 37 UK Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 38 UK Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 39 UK Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 40 UK Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 41 France Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 42 France Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 43 France Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 44 France Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 45 France Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 46 Italy Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 47 Italy Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 48 Italy Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 49 Italy Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 50 Italy Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 51 Spain Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 52 Spain Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 53 Spain Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 54 Spain Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 55 Spain Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 56 Denmark Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 57 Denmark Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 58 Denmark Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 59 Denmark Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 60 Denmark Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 61 Sweden Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 62 Sweden Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 63 Sweden Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 64 Sweden Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 65 Sweden Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 66 Norway Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 67 Norway Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 68 Norway Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 69 Norway Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 70 Norway Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 71 Asia-Pacific Genetic Disease Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 72 Asia-Pacific Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 73 Asia-Pacific Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 74 Asia-Pacific Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 75 Asia-Pacific Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 76 Asia-Pacific Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 77 China Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 78 China Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 79 China Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 80 China Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 81 China Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 82 Japan Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 83 Japan Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 84 Japan Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 85 Japan Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 86 Japan Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 87 India Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 88 India Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 89 India Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 90 India Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 91 India Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 92 South Korea Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 93 South Korea Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 94 South Korea Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 95 South Korea Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 96 South Korea Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 97 Australia Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 98 Australia Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 99 Australia Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 100 Australia Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 101 Australia Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 102 Thailand Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 103 Thailand Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 104 Thailand Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 105 Thailand Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 106 Thailand Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 107 Latin America Genetic Disease Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 108 Latin America Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 109 Latin America Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 110 Latin America Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 111 Latin America Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 112 Latin America Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 113 Brazil Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 114 Brazil Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 115 Brazil Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 116 Brazil Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 117 Brazil Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 118 Mexico Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 119 Mexico Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 120 Mexico Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 121 Mexico Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 122 Mexico Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 123 Argentina Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 124 Argentina Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 125 Argentina Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 126 Argentina Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 127 Argentina Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 128 Middle East & Africa Genetic Disease Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 129 Middle East & Africa Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 130 Middle East & Africa Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 131 Middle East & Africa Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 132 Middle East & Africa Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 133 Middle East & Africa Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 134 South Africa Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 135 South Africa Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 136 South Africa Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 137 South Africa Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 138 South Africa Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 139 Saudi Arabia Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 140 Saudi Arabia Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 141 Saudi Arabia Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 142 Saudi Arabia Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 143 Saudi Arabia Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 144 UAE Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 145 UAE Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 146 UAE Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 147 UAE Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 148 UAE Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 149 Kuwait Genetic Disease Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 150 Kuwait Genetic Disease Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 151 Kuwait Genetic Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 152 Kuwait Genetic Disease Diagnostics Market, by Channel, 2021-2033 (USD Million)
Table 153 Kuwait Genetic Disease Diagnostics Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Genetic Disease Diagnostics Market Segmentation
Figure 8 Market Snapshot, 2022
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 14 Porter’s Five Forces Analysis
Figure 15 Global Genetic Disease Diagnostics Market, Technology Movement Analysis
Figure 16 Global Genetic Disease Diagnostics Market, for Next Generation Sequencing, 2021-2033 (USD Million)
Figure 17 Global Genetic Disease Diagnostics Market, for Array Technology, 2021-2033 (USD Million)
Figure 18 Global Genetic Disease Diagnostics Market, for PCR-based Testing, 2021-2033 (USD Million)
Figure 19 Global Genetic Disease Diagnostics Market, for FISH, 2021-2033 (USD Million)
Figure 20 Global Genetic Disease Diagnostics Market, for Others, 2021-2033 (USD Million)
Figure 21 Global Genetic Disease Diagnostics Market, Application Movement Analysis
Figure 22 Global Genetic Disease Diagnostics Market, for Ancestry & Ethnicity, 2021-2033 (USD Million)
Figure 23 Global Genetic Disease Diagnostics Market, for Traits Screening, 2021-2033 (USD Million)
Figure 24 Global Genetic Disease Diagnostics Market, for Genetic Disease Carrier Status, 2021-2033 (USD Million)
Figure 25 Global Genetic Disease Diagnostics Market, for New Baby Screening, 2021-2033 (USD Million)
Figure 26 Global Genetic Disease Diagnostics Market, for Health and Wellness - Predisposition/Risk/ Tendency, 2021-2033 (USD Million)
Figure 27 Global Genetic Disease Diagnostics Market, Product Movement Analysis
Figure 28 Global Genetic Disease Diagnostics Market, for Consumables, Movement Analysis
Figure 29 Global Genetic Disease Diagnostics Market, for Equipment, 2021-2033 (USD Million)
Figure 30 Global Genetic Disease Diagnostics Market, for Software & Services, 2021-2033 (USD Million)
Figure 31 Global Genetic Disease Diagnostics Market, Channel Movement Analysis
Figure 32 Global Genetic Disease Diagnostics Market, for Online, 2021-2033 (USD Million)
Figure 33 Global Genetic Disease Diagnostics Market, for Offline, 2021-2033 (USD Million)
Figure 34 Global Genetic Disease Diagnostics Market, End Use Movement Analysis
Figure 35 Global Genetic Disease Diagnostics Market, for Hospitals & Clinics, 2021-2033 (USD Million)
Figure 36 Global Genetic Disease Diagnostics Market, for Diagnostic Laboratories, 2021-2033 (USD Million)
Figure 37 Global Genetic Disease Diagnostics Market, for Others, 2021-2033 (USD Million)
Figure 38 Regional Marketplace: Key Takeaways
Figure 39 Regional Outlook, 2024 & 2033
Figure 40 Global Genetic Disease Diagnostics Market, Region Movement Analysis
Figure 41 North America Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 42 U.S. Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 43 Canada Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 44 Europe Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 45 Germany Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 46 UK Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 47 France Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 48 Italy Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 49 Spain Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 50 Denmark Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 51 Sweden Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 52 Norway Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 53 Asia-Pacific Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 54 Japan Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 55 China Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 56 India Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 57 Australia Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 58 South Korea Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 59 Thailand Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 60 Latin America Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 61 Brazil Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 62 Mexico Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 63 Argentina Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 64 Middle East and Africa Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 65 South Africa Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 66 Saudi Arabia Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 67 UAE Genetic Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 68 Kuwait Genetic Disease Diagnostics Market, 2021-2033 (USD Million)

Companies Mentioned

The key companies profiled in this Genetic Disease Diagnostics market report include:
  • 24 genetics
  • Circle DNA
  • Tellmegen
  • 23andme
  • AncestryDNA
  • MyDNA
  • Everly Well
  • Igenomix
  • VitaGen
  • Myriad Genetics, Inc.
  • Mapmygenome
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Illumina, Inc.
  • Color Genomics, Inc.
  • Amgen, Inc.
  • Beyond Nutrition Health and Wellness Services DMCC

Table Information

Report AttributeDetails
No. of Pages120
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 11.71 Billion
Forecasted Market Value ( USD ) by 2033 $ 57.83 Billion
Compound Annual Growth Rate19.1%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Lung Cancer Diagnostics Market Size, Share & Trends Analysis Report by Type (Small Cell Lung Cancer, Non-Small Cell Lung Cancer), by Test (CA Tests, HER2 Tests, ALK Tests), by End Use, Region and Segment Forecasts, 2025-2033 - Product Image

Lung Cancer Diagnostics Market Size, Share & Trends Analysis Report by Type (Small Cell Lung Cancer, Non-Small Cell Lung Cancer), by Test (CA Tests, HER2 Tests, ALK Tests), by End Use, Region and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Gastric Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type (Adenocarcinoma, Gastric lymphoma), By End Use, By Region And Segment Forecasts, 2025 - 2033 - Product Image

Gastric Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type (Adenocarcinoma, Gastric lymphoma), By End Use, By Region And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Middle East Gastric Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents & Consumables, Instruments), by Disease (Adenocarcinoma), by End Use (Diagnostic laboratories), by Country, and Segment Forecasts, 2025-2033 - Product Image

Middle East Gastric Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents & Consumables, Instruments), by Disease (Adenocarcinoma), by End Use (Diagnostic laboratories), by Country, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Middle East
From
Hereditary Cancer Testing Market Size, Share & Trends Analysis Report by Cancer, by Technology (Cytogenetic, Biochemical, Molecular Testing), by Test Type (Predictive Testing, Diagnostic Testing), by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

Hereditary Cancer Testing Market Size, Share & Trends Analysis Report by Cancer, by Technology (Cytogenetic, Biochemical, Molecular Testing), by Test Type (Predictive Testing, Diagnostic Testing), by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Transplant Diagnostics Market Forecast to 2033 - Product Image

Transplant Diagnostics Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.